Tapewire

Nasdaq · USD

TMCI

TREACE MEDICAL CONCEPTS, INC.

Export transactions ↓
Tapewire entity
5943
SEC CIK
0001630627
Parsed reports
290

Last 12 months

Inside the activity.

14 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202660
Jun 202650
Jul 202600
Aug 202630
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 14, 2023 Filed Mar 15, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 9,400 $23.25 $218,533.08
Disclosure

SEC source: 0001209191-23-019078 · doc4.xml · nonDerivative · entry 3

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,263,483

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.0400 to $23.6250 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 13, 2023 Filed Mar 15, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 1,080 $24.73 $26,708.94
Disclosure

SEC source: 0001209191-23-019078 · doc4.xml · nonDerivative · entry 2

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,272,883

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.6300 to $24.9000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 13, 2023 Filed Mar 15, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 8,320 $24.07 $200,288.19
Disclosure

SEC source: 0001209191-23-019078 · doc4.xml · nonDerivative · entry 1

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,273,963

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.6300 to $24.5200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 10, 2023 Filed Mar 11, 2023 02:00 UTC
Scanlan Sean F.Chief Innovation Officer
GrantStock Option (Right to Buy) · Derivative 51,950 $0.00 Strike: $24.07 $0.00
Disclosure

SEC source: 0001209191-23-018042 · doc4.xml · derivative · entry 3

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,950

Underlying: Stock Option (Right to Buy) · 51,950 shares

Expires 2033-03-10

F5 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
March 10, 2023 Filed Mar 11, 2023 02:00 UTC
Scanlan Sean F.Chief Innovation Officer
GrantCommon Stock 22,925 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018042 · doc4.xml · nonDerivative · entry 2

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,395

F3 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F4 · balance_after: Includes 31,256 RSUs.

Read SEC document
March 10, 2023 Filed Mar 10, 2023 21:00 UTC
Owens Daniel E.Chief Human Resources Officer
GrantStock Option Right to Buy · Derivative 46,750 $0.00 Strike: $24.07 $0.00
Disclosure

SEC source: 0001209191-23-018043 · doc4.xml · derivative · entry 3

Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,750

Underlying: Stock Option Right to Buy · 46,750 shares

Expires 2033-03-10

F5 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
March 10, 2023 Filed Mar 10, 2023 21:00 UTC
Owens Daniel E.Chief Human Resources Officer
GrantCommon Stock 20,625 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018043 · doc4.xml · nonDerivative · entry 2

Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,914

F3 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F4 · balance_after: Includes 25,650 RSUs.

Read SEC document
March 10, 2023 Filed Mar 11, 2023 02:00 UTC
Treace John T.Director · Chief Executive Offer · 10% owner
GrantStock Option (Right to Buy) · Derivative 186,900 $0.00 Strike: $24.07 $0.00
Disclosure

SEC source: 0001209191-23-018046 · doc4.xml · derivative · entry 7

Treace John T. · CIK 0001856380 · Director · Chief Executive Offer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,900

Underlying: Stock Option (Right to Buy) · 186,900 shares

Expires 2033-03-10

F7 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
March 10, 2023 Filed Mar 11, 2023 02:00 UTC
Treace John T.Director · Chief Executive Offer · 10% owner
GrantCommon Stock 82,475 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018046 · doc4.xml · nonDerivative · entry 2

Treace John T. · CIK 0001856380 · Director · Chief Executive Offer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,621,855

F3 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F4 · balance_after: Includes 107,881 RSUs.

Read SEC document
March 10, 2023 Filed Mar 11, 2023 02:00 UTC
Hair MarkChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 103,850 $0.00 Strike: $24.07 $0.00
Disclosure

SEC source: 0001209191-23-018045 · doc4.xml · derivative · entry 4

Hair Mark · CIK 0001725070 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,850

Underlying: Stock Option (Right to Buy) · 103,850 shares

Expires 2033-03-10

F6 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
March 10, 2023 Filed Mar 11, 2023 02:00 UTC
Hair MarkChief Financial Officer
GrantCommon Stock 45,825 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018045 · doc4.xml · nonDerivative · entry 2

Hair Mark · CIK 0001725070 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,935

F3 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F4 · balance_after: Includes 54,787 RSUs.

Read SEC document
March 10, 2023 Filed Mar 11, 2023 02:00 UTC
Berutti AaronSr. VP, Sales
GrantStock Option (Right to Buy) · Derivative 67,500 $0.00 Strike: $24.07 $0.00
Disclosure

SEC source: 0001209191-23-018044 · doc4.xml · derivative · entry 3

Berutti Aaron · CIK 0001871334 · Sr. VP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,500

Underlying: Stock Option (Right to Buy) · 67,500 shares

Expires 2033-03-10

F5 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
March 10, 2023 Filed Mar 11, 2023 02:00 UTC
Berutti AaronSr. VP, Sales
GrantCommon Stock 29,800 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018044 · doc4.xml · nonDerivative · entry 2

Berutti Aaron · CIK 0001871334 · Sr. VP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,842

F3 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F4 · balance_after: Includes 38,762 RSUs.

Read SEC document
March 10, 2023 Filed Mar 11, 2023 02:00 UTC
Elder Scot Michael*See "Remarks"
GrantStock Option (Right to Buy) · Derivative 62,300 $0.00 Strike: $24.07 $0.00
Disclosure

SEC source: 0001209191-23-018041 · doc4.xml · derivative · entry 3

Elder Scot Michael · CIK 0001916619 · *See "Remarks"

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,300

Underlying: Stock Option (Right to Buy) · 62,300 shares

Expires 2033-03-10

F5 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
March 10, 2023 Filed Mar 11, 2023 02:00 UTC
Elder Scot Michael*See "Remarks"
GrantCommon Stock 27,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018041 · doc4.xml · nonDerivative · entry 2

Elder Scot Michael · CIK 0001916619 · *See "Remarks"

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,921

F3 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F4 · balance_after: Includes 45,643 RSUs.

Read SEC document
March 09, 2023 Filed Mar 11, 2023 02:00 UTC
Scanlan Sean F.Chief Innovation Officer
SaleCommon Stock 505 $24.41 $12,327.05
Disclosure

SEC source: 0001209191-23-018042 · doc4.xml · nonDerivative · entry 1

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,470

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · balance_after: Includes 8,331 RSUs.

Read SEC document
March 09, 2023 Filed Mar 10, 2023 21:00 UTC
Owens Daniel E.Chief Human Resources Officer
SaleCommon Stock 411 $24.41 $10,032.51
Disclosure

SEC source: 0001209191-23-018043 · doc4.xml · nonDerivative · entry 1

Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,289

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · balance_after: Includes 5,025 RSUs.

Read SEC document
March 09, 2023 Filed Mar 11, 2023 02:00 UTC
Treace John T.Director · Chief Executive Offer · 10% owner
SaleCommon Stock 2,075 $24.41 $50,650.75
Disclosure

SEC source: 0001209191-23-018046 · doc4.xml · nonDerivative · entry 1

Treace John T. · CIK 0001856380 · Director · Chief Executive Offer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,539,380

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · balance_after: Includes 25,406 restricted stock units.

Read SEC document
March 09, 2023 Filed Mar 11, 2023 02:00 UTC
Hair MarkChief Financial Officer
SaleCommon Stock 1,040 $24.41 $25,386.40
Disclosure

SEC source: 0001209191-23-018045 · doc4.xml · nonDerivative · entry 1

Hair Mark · CIK 0001725070 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,110

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · balance_after: Includes 8,962 RSUs.

Read SEC document
March 09, 2023 Filed Mar 10, 2023 21:00 UTC SaleCommon Stock 1,502 $26.00 $39,052.00
Disclosure

SEC source: 0001209191-23-018040 · doc4.xml · nonDerivative · entry 3

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,058,498

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · balance_after: Includes 2,295 RSUs.

Read SEC document
March 09, 2023 Filed Mar 11, 2023 02:00 UTC
Berutti AaronSr. VP, Sales
SaleCommon Stock 733 $24.41 $17,892.53
Disclosure

SEC source: 0001209191-23-018044 · doc4.xml · nonDerivative · entry 1

Berutti Aaron · CIK 0001871334 · Sr. VP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,042

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · balance_after: Includes 8,962 RSUs.

Read SEC document
March 09, 2023 Filed Mar 11, 2023 02:00 UTC
Elder Scot Michael*See "Remarks"
SaleCommon Stock 177 $24.41 $4,320.57
Disclosure

SEC source: 0001209191-23-018041 · doc4.xml · nonDerivative · entry 1

Elder Scot Michael · CIK 0001916619 · *See "Remarks"

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,421

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · price: Includes 18,143 RSUs.

F2 · balance_after: Includes 18,143 RSUs.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 21:00 UTC SaleCommon Stock 20,000 $24.00 $480,002.00
Disclosure

SEC source: 0001209191-23-018040 · doc4.xml · nonDerivative · entry 2

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,060,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.0000 to $24.0100 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 2,295 RSUs.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 21:00 UTC SaleCommon Stock 25,000 $22.50 $562,500.00
Disclosure

SEC source: 0001209191-23-018040 · doc4.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,080,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · balance_after: Includes 2,295 RSUs.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:00 UTC SaleCommon Stock 12,684 $21.36 $270,930.24
Disclosure

SEC source: 0001209191-23-015075 · doc4.xml · nonDerivative · entry 2

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 961,441

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.9700 to $21.5200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 21:00 UTC SaleCommon Stock 50,000 $21.35 $1,067,545.00
Disclosure

SEC source: 0001209191-23-016093 · doc4.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,105,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.2000 to $21.5500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 2,295 RSUs.

Read SEC document
February 28, 2023 Filed Mar 2, 2023 21:00 UTC SaleCommon Stock 37,316 $21.54 $803,786.64
Disclosure

SEC source: 0001209191-23-015075 · doc4.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 974,125

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.4100 to $22.2250 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 22, 2023 Filed Feb 23, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 9,400 $21.97 $206,534.92
Disclosure

SEC source: 0001209191-23-012441 · doc4.xml · nonDerivative · entry 2

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,282,283

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.7150 to $22.1800 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 9,400 $21.74 $204,352.24
Disclosure

SEC source: 0001209191-23-012441 · doc4.xml · nonDerivative · entry 1

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,291,683

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.4200 to $22.0400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 17:52 UTC GiftCommon Stock 8,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-010852 · doc4.xml · nonDerivative · entry 2

TIMBIE THOMAS E · CIK 0001188309 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Pamela Timbie and Thomas Timbie as Trustees of the PAMELA F TIMBIE REV TRUST

Disclosed balance after: 361,700

Read SEC document
February 15, 2023 Filed Feb 18, 2023 02:00 UTC
Scanlan Sean F.Chief Innovation Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.10 Strike: $0.10 $2,500.00
Disclosure

SEC source: 0001209191-23-010955 · doc4.xml · derivative · entry 3

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,750

Underlying: Common Stock · 25,000 shares

Expires 2024-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 15, 2023 Filed Feb 18, 2023 02:00 UTC
Scanlan Sean F.Chief Innovation Officer
SaleCommon Stock 25,000 $21.69 $542,235.00
Disclosure

SEC source: 0001209191-23-010955 · doc4.xml · nonDerivative · entry 2

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,975

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.5000 to $21.9900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 9,975 RSUs.

Read SEC document
February 15, 2023 Filed Feb 18, 2023 02:00 UTC
Scanlan Sean F.Chief Innovation Officer
Exercise / conversionCommon Stock 25,000 $0.10 $2,500.00
Disclosure

SEC source: 0001209191-23-010955 · doc4.xml · nonDerivative · entry 1

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,975

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · balance_after: Includes 9,975 RSUs.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 17:52 UTC SaleCommon Stock 50,000 $21.71 $1,085,350.00
Disclosure

SEC source: 0001209191-23-010852 · doc4.xml · nonDerivative · entry 1

TIMBIE THOMAS E · CIK 0001188309 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001

Disclosed balance after: 1,199,069

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.4800 to $22.1380 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 08, 2023 Filed Feb 9, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 27,731 $21.71 $601,901.36
Disclosure

SEC source: 0001209191-23-008200 · doc4.xml · nonDerivative · entry 2

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,301,083

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.4000 to $22.0100 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 07, 2023 Filed Feb 9, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 8,800 $23.00 $202,366.56
Disclosure

SEC source: 0001209191-23-008200 · doc4.xml · nonDerivative · entry 1

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,328,814

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.8700 to $23.3100 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 02, 2023 Filed Feb 3, 2023 21:00 UTC SaleCommon Stock 4,011 $24.00 $96,264.00
Disclosure

SEC source: 0001209191-23-007201 · doc4.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,155,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · balance_after: Includes 2,295 RSUs.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 21:00 UTC SaleCommon Stock 11,929 $23.19 $276,633.51
Disclosure

SEC source: 0001209191-23-006465 · doc4.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,011,441

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.8000 to $23.6000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 30, 2023 Filed Jan 30, 2023 18:35 UTC SaleCommon sotk 1,054 $24.55 $25,879.71
Disclosure

SEC source: 0001209191-23-005547 · doc4.xml · nonDerivative · entry 3

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,023,370

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.3600 to $25.0600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 30, 2023 Filed Jan 30, 2023 18:35 UTC SaleCommon Stock 8,803 $23.68 $208,411.91
Disclosure

SEC source: 0001209191-23-005547 · doc4.xml · nonDerivative · entry 2

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,024,424

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.3500 to $24.3300 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 30, 2023 Filed Jan 30, 2023 18:35 UTC SaleCommon Stock 28,214 $23.00 $648,800.68
Disclosure

SEC source: 0001209191-23-005547 · doc4.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,033,227

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.3500 to $23.3400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 30, 2023 Filed Jan 30, 2023 18:30 UTC SaleCommon Stock 2,039 $24.58 $50,120.46
Disclosure

SEC source: 0001209191-23-005543 · doc4.xml · nonDerivative · entry 3

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,159,011

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.4150 to $25.1300 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 2,295 RSUs.

Read SEC document
January 30, 2023 Filed Jan 30, 2023 18:30 UTC SaleCommon Stock 27,422 $23.87 $654,601.53
Disclosure

SEC source: 0001209191-23-005543 · doc4.xml · nonDerivative · entry 2

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,161,050

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.4100 to $24.4000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 2,295 RSUs.

Read SEC document
January 30, 2023 Filed Jan 30, 2023 18:30 UTC SaleCommon Stock 61,528 $22.92 $1,410,449.41
Disclosure

SEC source: 0001209191-23-005543 · doc4.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,188,472

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.4000 to $23.3950 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 2,295 RSUs.

Read SEC document
January 25, 2023 Filed Jan 26, 2023 21:13 UTC
BAYS F BARRYDirector
SaleCommon Stock 7,255 $25.73 $186,658.82
Disclosure

SEC source: 0001209191-23-005131 · doc4.xml · nonDerivative · entry 3

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,337,614

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.6600 to $25.8100 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 25, 2023 Filed Jan 26, 2023 21:13 UTC
BAYS F BARRYDirector
SaleCommon Stock 20,467 $25.28 $517,440.55
Disclosure

SEC source: 0001209191-23-005131 · doc4.xml · nonDerivative · entry 2

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,344,869

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.6600 to $25.6500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 24, 2023 Filed Jan 26, 2023 21:13 UTC
BAYS F BARRYDirector
SaleCommon Stock 25,921 $26.03 $674,744.37
Disclosure

SEC source: 0001209191-23-005131 · doc4.xml · nonDerivative · entry 1

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,365,336

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.7700 to $26.3700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 18, 2023 Filed Jan 20, 2023 21:00 UTC SaleCommon Stock 50,000 $25.88 $1,294,000.00
Disclosure

SEC source: 0001209191-23-004342 · doc4.xml · nonDerivative · entry 1

TIMBIE THOMAS E · CIK 0001188309 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001

Disclosed balance after: 1,249,069

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5400 to $26.5000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 17, 2023 Filed Jan 19, 2023 21:00 UTC SaleCommon Stock 11,014 $26.00 $286,377.22
Disclosure

SEC source: 0001209191-23-004143 · doc4.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.0400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 2,295 RSUs.

Read SEC document
January 13, 2023 Filed Jan 13, 2023 21:00 UTC SaleCommon Stock 6,519 $26.00 $169,494.65
Disclosure

SEC source: 0001209191-23-003384 · doc4.xml · nonDerivative · entry 2

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,261,014

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.0075 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 2,295 RSUs.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.